More EU news is available on the wire services of the respective news agency.
The EU has moved to reassure the European pharmaceuticals industry after US President Donald Trump’s announcement of tariffs on pharmaceuticals caused concern.
US President Donald Trump speaks at the General Debate of the UN General Assembly. Photo: Kay Nietfeld/dpa
Have the article read by OpenAI (Beta). Please note that AI translations may take some time to process.
Washington/Brussels (dpa) – The European Commission expects pharmaceutical exports from the European Union to be exempt from the 100 percent tariffs announced by US President Donald Trump, a spokesman in Brussels said on Friday.
Trump announced on Thursday that, from October 1, the United States would impose a 100 percent tariff on all trademark-protected or patented pharmaceuticals unless a company built its manufacturing facilities in the United States.
On his Truth Social platform, Trump defined the construction of a pharmaceutical plant as either “breaking ground” or being “under construction.”
The tariffs are expected to hit countries such as India, a major supplier of pharmaceuticals to the US.
German pharmaceutical firms are also concerned, as the US is their most important export market, accounting for nearly a quarter of German pharma exports.
The spokesman in Brussels said the joint EU-US statement on trade agreed in August clearly stated that a 15 percent tariff cap applied to EU exports in the pharmaceuticals sector. This gave assurance that no higher duties would arise for European economic operators, he added. (26 September)
The editorial responsibility for the publication lies with dpa.
